BOSTON, MA, April 27, 2022—Virb, Inc. is pleased to announce that Bernard Dyson has joined the company as Chief Financial and Operations Officer. Dyson brings 30 years of experience in the pharmaceutical and life sciences industry, most recently as senior vice president, financial planning & analysis at Syneos Health, where he led the FP&A function and a successful enterprise-wide margin improvement initiative.
Dyson began his career with Ernst & Young, where he earned his Chartered Accountancy qualification. He worked at Covance and IQVIA, progressing from financial controller of a small Phase I unit in the UK to vice president of global finance based in North Carolina—having relocated to the USA in 2000. Dyson then moved into a sales-related role as vice president of strategic pricing & negotiations, leading the commercial discussions for several large customer partnerships before joining Syneos Health. He’s been a key stakeholder in strategic and operational planning, and customer negotiations.
“Bernard brings unique industry experience in negotiation, pricing, and operations to Virb,” says Founder and CEO Garrett Walker. “He’ll bring a valued perspective in meeting the needs of our clients.” Dyson adds, “I’m excited to join the Virb team. There’s a clear need in the CRO industry to explore new approaches to resourcing, and I believe Virb’s business model will significantly improve CROs’ ability to meet the increasing demand for their services.”
Virb is the first cloud-based end-to-end human capital resource management platform that sources, trains, and deploys new talent into the clinical research industry. Our purpose is to create a people-centric clinical trial ecosystem that helps improve and save lives. Learn more at virb.io.